Tech Company Inital Public Offerings
Progyny IPO
Progyny was acquired by . The company's stock became public on 10/24/2019.
Transaction Overview
Company Name
Announced On
10/24/2019
Transaction Type
IPO
Amount
$130,000,000
Proceeds Purpose
However, we currently intend to use the net proceeds we receive from this offering for general corporate purposes, including working capital, operating expenses and capital expenditures. We may also use a portion of the net proceeds to acquire complementary businesses, services or technologies. However, we do not have agreements or commitments to enter into any acquisitions at this time.
Company Information
Company Status
Publicly-held
Industry
Healthcare Services
Mailing Address
99 Hudson St. 7th Floor
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Website
Email Address
Overview
Progyny (Nasdaq: PGNY) is the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, and financing, coupled with extraordinary clinical expertise and proprietary clinical solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Schlanger
Chief Financial Officer
Mark Livingston
Chief Medical Officer
Alan Copperman
Chief Operating Officer
Peter Anevski
VP - Client Services
Lisa Greenbaum
VP - Marketing
Risa Fisher
Browse more venture capital transactions:
Prev: 10/24/2019: Elate venture capital transaction
Next: 10/24/2019: Vendr venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs